<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Elsevier Global Medical News - US Top Stories</title>
    <link>http://www.imng.com</link>
    <description>Elsevier Global Medical News Group has provided physician specialists with authoritative coverage of medical meetings, breaking medical news and analysis, clinical trial results, updates on drug prescribing, pertinent summaries of clinical guidelines, and perspective and opinion from medicine thought leaders.</description>
    <copyright>Copyright 2012 Elsevier Global Medical News. All rights reserved.</copyright>
    <language>en-us</language>
    <pubDate>Sat, 04 Feb 2012 12:30:09 GMT</pubDate>
    <generator>InfoDesk</generator>
    <image>
      <url>http://media.ny.idsk.com/multimedia/logos/rsslogo_imng.gif</url>
      <title>Elsevier Global Medical News Group</title>
      <link>http://www.imng.com</link>
    </image>
    <item>
      <title>MDV3100 Cuts Risk of Death in Advanced Prostate Cancer</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020320121406369525.html?APP=7&amp;CU=imn5804</link>
      <description>SAN FRANCISCO (EGMN) &#8211; MDV3100, new oral inhibitor of androgen receptor signaling, reduces the risk of death by more than a third after a failure of docetaxel chemotherapy in men with progressive castration-resistant prostate cancer, according to results of the randomized <a href="http://clinicaltrials.gov/ct2/show/NCT00974311">AFFIRM</a> trial. </description>
      <author>BY SUSAN LONDON</author>
      <pubDate>Fri, 03 Feb 2012 19:06:36 GMT</pubDate>
      <guid isPermaLink="false">imn020320121406369525</guid>
    </item>
    <item>
      <title>Anemia Triples Post-Stroke Mortality Risk</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020320121026009495.html?APP=7&amp;CU=imn5804</link>
      <description>NEW ORLEANS (EGMN) &#8211; Patients with a very low or a very high hematocrit are at higher risk for death after a stroke, and anemic patients are at greatest risk, according to a study presented at the International Stroke Conference sponsored by the American Heart Association on Feb. 2.</description>
      <author>BY ALICIA AULT</author>
      <pubDate>Fri, 03 Feb 2012 15:26:00 GMT</pubDate>
      <guid isPermaLink="false">imn020320121026009495</guid>
    </item>
    <item>
      <title>Intracranial Bleed Risk Higher in Warfarin Than Rivaroxaban Users</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020220122049009493.html?APP=7&amp;CU=imn5804</link>
      <description>
            <scaps>NEW ORLEANS</scaps>
            <scaps> (EGMN)</scaps>
            <scaps>
            </scaps>
            <scaps>&#8211;</scaps> Compared with warfarin, the new-generation anticoagulant rivaroxaban was associated with a 40% lower risk of intracranial hemorrhage in patients with atrial fibrillation who were taking the agents to prevent stroke.</description>
      <author>BY MICHELE G. SULLIVAN</author>
      <pubDate>Fri, 03 Feb 2012 01:49:00 GMT</pubDate>
      <guid isPermaLink="false">imn020220122049009493</guid>
    </item>
    <item>
      <title>Longer Monitoring Needed to Detect Cause of Cryptogenic Stroke</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020220121727099490.html?APP=7&amp;CU=imn5804</link>
      <description>NEW ORLEANS (EGMN) &#8211; Continuous cardiac outpatient telemetry monitoring for at least 21 days may be necessary to accurately identify atrial fibrillation as the cause of cryptogenic stroke, according to the results of a <a href="http://newsroom.heart.org/pr/aha/document/C1_-_THURS_150_2392_Miller_abstract_PAF.docx">single-center, retrospective study</a>.</description>
      <author>BY ALICIA AULT</author>
      <pubDate>Thu, 02 Feb 2012 22:27:09 GMT</pubDate>
      <guid isPermaLink="false">imn020220121727099490</guid>
    </item>
    <item>
      <title>Vets With PTSD: Individualized Vocational Support Ups Employment Odds </title>
  <link>http://infoviewer.biz/infodisplay/story/imn020220120001099469.html?APP=7&amp;CU=imn5804</link>
      <description>Unemployed veterans with post-traumatic stress disorder experience better employment outcomes when they receive individual job placement and support services, compared with standard vocational rehabilitation services, new research shows.</description>
      <author>BY DIANA MAHONEY</author>
      <pubDate>Thu, 02 Feb 2012 05:01:09 GMT</pubDate>
      <guid isPermaLink="false">imn020220120001099469</guid>
    </item>
    <item>
      <title>Infection Correlated With Stroke Risk in Children</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020120122027379468.html?APP=7&amp;CU=imn5804</link>
      <description>
            <scaps>NEW ORLEANS</scaps>
            <scaps> (EGMN)</scaps>
            <scaps>
            </scaps>
            <scaps>&#8211;</scaps>
            <scaps>
            </scaps>There may be a correlation between infection and stroke in children, according to research presented at the International Stroke Conference.</description>
      <author>BY ALICIA AULT</author>
      <pubDate>Thu, 02 Feb 2012 01:27:37 GMT</pubDate>
      <guid isPermaLink="false">imn020120122027379468</guid>
    </item>
    <item>
      <title>Memory Declines Years Before Stroke Strikes</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020120121924309466.html?APP=7&amp;CU=imn5804</link>
      <description>
            <scaps>NEW ORLEANS</scaps>
            <scaps> (EGMN) </scaps>
            <scaps>&#8211;</scaps>
            <scaps>
            </scaps>Memory is already impaired years before a stroke occurs, declining most rapidly in people destined to suffer a fatal stroke, according to <a href="http://stroke.ahajournals.org/cgi/content/meeting_abstract/43/2_MeetingAbstracts/A31?sid=63a04c6e-e0b2-4b46-a285-77f604247c86">a population-based study</a> of more than 11,000 people.</description>
      <author>BY MICHELE G. SULLIVAN</author>
      <pubDate>Thu, 02 Feb 2012 00:24:30 GMT</pubDate>
      <guid isPermaLink="false">imn020120121924309466</guid>
    </item>
    <item>
      <title>Short-Term Ulipristal Found Effective for Uterine Fibroids</title>
  <link>http://infoviewer.biz/infodisplay/story/imn020120121700109455.html?APP=7&amp;CU=imn5804</link>
      <description>Short-term therapy with ulipristal acetate, a selective progesterone-receptor modulator, is superior to placebo and noninferior to leuprolide at controlling the bleeding, reducing the volume, and improving the pain of uterine fibroids, according to two reports in the Feb. 2 issue of the New England Journal of Medicine.</description>
      <author>BY MARY ANN MOON</author>
      <pubDate>Wed, 01 Feb 2012 22:00:10 GMT</pubDate>
      <guid isPermaLink="false">imn020120121700109455</guid>
    </item>
    <item>
      <title>GAD-alum Antigen Therapy Fails to Halt Progression of Type 1 Diabetes </title>
  <link>http://infoviewer.biz/infodisplay/story/imn020120121700059454.html?APP=7&amp;CU=imn5804</link>
      <description>Antigen therapy with glutamic acid decarboxylase 65 formulated with alum failed to induce immunologic tolerance and stem the loss of stimulated serum C-peptide in a phase III clinical trial of new-onset type 1 diabetes, according to a report in the Feb. 2 issue of the New England Journal of Medicine. </description>
      <author>BY MARY ANN MOON</author>
      <pubDate>Wed, 01 Feb 2012 22:00:05 GMT</pubDate>
      <guid isPermaLink="false">imn020120121700059454</guid>
    </item>
    <item>
      <title>ASCO GU to Spotlight Prostate Cancer Drugs MDV3100 and Radium-223 </title>
  <link>http://infoviewer.biz/infodisplay/story/imn013120121800009418.html?APP=7&amp;CU=imn5804</link>
      <description>The <a href="http://www.gucasymposium.org/">2012 Genitourinary Cancers Symposium</a>, to be held Feb. 2-4, will feature potentially practice-changing data on two novel agents &#8211; MDV3100 and radium-223 chloride &#8211; in prostate cancer.</description>
      <author>BY SUSAN LONDON</author>
      <pubDate>Tue, 31 Jan 2012 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">imn013120121800009418</guid>
    </item>
    <item>
      <title>FDA Quickly Approves &apos;Breakthrough&apos; Cystic Fibrosis Drug </title>
  <link>http://infoviewer.biz/infodisplay/story/imn013120121602089406.html?APP=7&amp;CU=imn5804</link>
      <description>The Food and Drug Administration on Jan. 31 approved the drug ivacaftor (Kalydeco) for cystic fibrosis patients aged 6 years and older who have the G551D mutation.</description>
      <author>BY ALICIA AULT</author>
      <pubDate>Tue, 31 Jan 2012 21:02:08 GMT</pubDate>
      <guid isPermaLink="false">imn013120121602089406</guid>
    </item>
    <item>
      <title>Patients Don&apos;t Linger Longer in Safety-Net EDs </title>
  <link>http://infoviewer.biz/infodisplay/story/imn013120121600189399.html?APP=7&amp;CU=imn5804</link>
      <description>Emergency departments at &#8220;safety-net&#8221; hospitals showed timelines similar to those of  EDs in other hospitals for admitting, discharging, or transferring patients, according to a national survey published in the Feb. 1 issue of JAMA.</description>
      <author>BY MARY ANN MOON</author>
      <pubDate>Tue, 31 Jan 2012 21:00:18 GMT</pubDate>
      <guid isPermaLink="false">imn013120121600189399</guid>
    </item>
    <item>
      <title>Re-Excision Rates After Breast-Conserving Surgery Vary Greatly</title>
  <link>http://infoviewer.biz/infodisplay/story/imn013120121600199401.html?APP=7&amp;CU=imn5804</link>
      <description>Rates of re-excision after initial breast-conserving surgery for invasive breast cancer vary greatly across surgeons and across medical centers, according to a report in the Feb. 1 issue of JAMA. </description>
      <author>BY MARY ANN MOON</author>
      <pubDate>Tue, 31 Jan 2012 21:00:19 GMT</pubDate>
      <guid isPermaLink="false">imn013120121600199401</guid>
    </item>
    <item>
      <title>TAVR Gets a Detailed Road Map</title>
  <link>http://infoviewer.biz/infodisplay/story/imn013120121444299384.html?APP=7&amp;CU=imn5804</link>
      <description>To ensure appropriate implementation and use of transcatheter aortic valve replacement in medical centers across the United States, four leading cardiovascular organizations have pooled their knowledge and issued a consensus document. </description>
      <author>BY NASEEM S. MILLER</author>
      <pubDate>Tue, 31 Jan 2012 19:44:29 GMT</pubDate>
      <guid isPermaLink="false">imn013120121444299384</guid>
    </item>
    <item>
      <title>Metformin May Lower Pancreatic Cancer Risk in Women</title>
  <link>http://infoviewer.biz/infodisplay/story/imn013120120800009372.html?APP=7&amp;CU=imn5804</link>
      <description>Metformin use was associated with a decreased risk of pancreatic cancer in women, but not in men, in a large case-control study involving more than 19,300 U.K. primary care patients.</description>
      <author>BY SHARON WORCESTER</author>
      <pubDate>Tue, 31 Jan 2012 13:00:00 GMT</pubDate>
      <guid isPermaLink="false">imn013120120800009372</guid>
    </item>
    <item>
      <title>Burn Size Remains Strongest Predictor of Pediatric Survival </title>
  <link>http://infoviewer.biz/infodisplay/story/imn013020121830089364.html?APP=7&amp;CU=imn5804</link>
      <description>For pediatric burn patients, the percentage of total body surface area affected remains the strongest predictor of survival, according to a report published online Jan. 31 in the Lancet.</description>
      <author>BY MARY ANN MOON</author>
      <pubDate>Mon, 30 Jan 2012 23:30:08 GMT</pubDate>
      <guid isPermaLink="false">imn013020121830089364</guid>
    </item>
    <item>
      <title>Vismodegib Receives FDA Approval for Metastatic BCC </title>
  <link>http://infoviewer.biz/infodisplay/story/imn013020121551069360.html?APP=7&amp;CU=imn5804</link>
      <description>The Food and Drug Administration has approved vismodegib, an oral, once-daily medication for adults with locally advanced and metastatic advanced basal cell carcinoma on Jan. 30.</description>
      <author>BY ALICIA AULT</author>
      <pubDate>Mon, 30 Jan 2012 20:51:06 GMT</pubDate>
      <guid isPermaLink="false">imn013020121551069360</guid>
    </item>
    <item>
      <title>Uncovering Reasons for Recurrent Pregnancy Loss </title>
  <link>http://infoviewer.biz/infodisplay/story/imn013020121509299352.html?APP=7&amp;CU=imn5804</link>
      <description>
          </description>
      <author>BY KRISTIN ATKINS, M.D.</author>
      <pubDate>Mon, 30 Jan 2012 20:09:29 GMT</pubDate>
      <guid isPermaLink="false">imn013020121509299352</guid>
    </item>
    <item>
      <title>Blood Pressure Differences Between Arms Flags Vascular Disease</title>
  <link>http://infoviewer.biz/infodisplay/story/imn013020121320349340.html?APP=7&amp;CU=imn5804</link>
      <description>A difference of 15 mm Hg or more in systolic blood pressure between a patient&#8217;s arms may signal the presence of asymptomatic peripheral vascular disease, according to a meta-analysis published online Jan. 30 in the Lancet.</description>
      <author>BY MARY ANN MOON</author>
      <pubDate>Mon, 30 Jan 2012 18:20:34 GMT</pubDate>
      <guid isPermaLink="false">imn013020121320349340</guid>
    </item>
    <item>
      <title>Study: Booster Seat Use During Carpooling Inconsistent</title>
  <link>http://infoviewer.biz/infodisplay/story/imn013020120001049314.html?APP=7&amp;CU=imn5804</link>
      <description>Only 55% of parents with children aged 4-8 years always have their child use a car booster seat when driving with other children in the car, according to a study published Jan. 30 in Pediatrics.</description>
      <author>BY JANE ANDERSON</author>
      <pubDate>Mon, 30 Jan 2012 05:01:04 GMT</pubDate>
      <guid isPermaLink="false">imn013020120001049314</guid>
    </item>
  </channel>
</rss>

